RxSight Statistics
Share Statistics
RxSight has 40.30M shares outstanding. The number of shares has increased by 10.66% in one year.
| Shares Outstanding | 40.30M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.8% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 38.27M |
| Failed to Deliver (FTD) Shares | 13.27K |
| FTD / Avg. Volume | 2.35% |
Short Selling Information
The latest short interest is 2.74M, so 6.81% of the outstanding shares have been sold short.
| Short Interest | 2.74M |
| Short % of Shares Out | 6.81% |
| Short % of Float | 7.18% |
| Short Ratio (days to cover) | 8.39 |
Valuation Ratios
The PE ratio is -28.58 and the forward PE ratio is -92.96.
| PE Ratio | -28.58 |
| Forward PE | -92.96 |
| PS Ratio | 15.6 |
| Forward PS | 8 |
| PB Ratio | 8.66 |
| P/FCF Ratio | -29.94 |
| PEG Ratio | n/a |
Enterprise Valuation
RxSight Inc. has an Enterprise Value (EV) of 1.38B.
| EV / Earnings | -28.44 |
| EV / Sales | 15.52 |
| EV / EBITDA | -33.69 |
| EV / EBIT | -27.6 |
| EV / FCF | -29.79 |
Financial Position
The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.
| Current Ratio | 8.06 |
| Quick Ratio | 7.22 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -15.14 |
Financial Efficiency
Return on equity (ROE) is -0.3% and return on capital (ROIC) is -30.67%.
| Return on Equity (ROE) | -0.3% |
| Return on Assets (ROA) | -0.27% |
| Return on Capital (ROIC) | -30.67% |
| Revenue Per Employee | 238.17K |
| Profits Per Employee | -129.97K |
| Employee Count | 374 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.03 |
Taxes
| Income Tax | 20.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -6.3% in the last 52 weeks. The beta is 1.19, so RxSight 's price volatility has been higher than the market average.
| Beta | 1.19 |
| 52-Week Price Change | -6.3% |
| 50-Day Moving Average | 47.24 |
| 200-Day Moving Average | 52.02 |
| Relative Strength Index (RSI) | 21.87 |
| Average Volume (20 Days) | 563.90K |
Income Statement
In the last 12 months, RxSight had revenue of $89.08M and earned -$48.61M in profits. Earnings per share was $-1.41.
| Revenue | 89.08M |
| Gross Profit | 53.77M |
| Operating Income | -50.09M |
| Net Income | -48.61M |
| EBITDA | -41.04M |
| EBIT | -50.09M |
| Earnings Per Share (EPS) | -1.41 |
Balance Sheet
The company has $9.69M in cash and $3.01M in debt, giving a net cash position of $6.68M.
| Cash & Cash Equivalents | 9.69M |
| Total Debt | 3.01M |
| Net Cash | 6.68M |
| Retained Earnings | -594.64M |
| Total Assets | 310.47M |
| Working Capital | 264.13M |
Cash Flow
In the last 12 months, operating cash flow was -$41.59M and capital expenditures -$4.81M, giving a free cash flow of -$46.41M.
| Operating Cash Flow | -41.59M |
| Capital Expenditures | -4.81M |
| Free Cash Flow | -46.41M |
| FCF Per Share | -1.35 |
Margins
Gross margin is 60.36%, with operating and profit margins of -56.23% and -54.57%.
| Gross Margin | 60.36% |
| Operating Margin | -56.23% |
| Pretax Margin | -54.55% |
| Profit Margin | -54.57% |
| EBITDA Margin | -46.07% |
| EBIT Margin | -56.23% |
| FCF Margin | -52.1% |
Dividends & Yields
RXST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3.79% |
| FCF Yield | -3.09% |
Analyst Forecast
The average price target for RXST is $65, which is 74.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $65 |
| Price Target Difference | 74.7% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 25.21 |
| Piotroski F-Score | 4 |